Publications

5600 Results

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer: SWOG S2107 (NCT05308446)

Authors
V Morris;K Guthrie;S Kopetz;R Breakstone;T Karasic;ZI Hu;S Colby;M Fakih;S Gholami;P Gold;PA Philip
Journal / Conference
J Clin Oncol 41, 2023 (suppl 4; abstr TPS265); ASCO GI Cancers Symposium (January 19-21, 2023, San Francisco, CA)
Year
2023
Research Committee(s)
Gastrointestinal
Study Number(s)
S2107

Thymidine Kinase Activity Levels in Serum Can Identify HR+ Metastatic Breast Cancer Patients with a Low Risk of Early Progression (SWOG S0226)

Authors
M Bergqvist;A Nordmark;A Williams;C Paoletti;W Barlow;E Cobain;R Mehta;J Gralow;G Hortobagyi;K Albain;L Pusztai;P Sharma;A Godwin;A Thompson;D Hayes;J Rae
Journal / Conference
Biomarkers Jan 29:1-10
Year
2023
Research Committee(s)
Breast
PMID
PMID36647745
PMC
PMC10681159
Study Number(s)
S0226

Neoadjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma

Authors
SP Patel;M Othus;Y Chen;GP Wright;K Yost;J Hyngstrom;S Hu-Lieskovan;C Lao;L Fecher;T-G Truong;J Eisenstein;S Chandra;J Sosman;K Kendra;R Wu;C Devoe;G Deutsch;A Hedge;M Khalil;A Reese;M Ross;A Poklepovic;G Phan;A Onitilo;D Gokalp Yasar;B Powers;G Doolittle;G In;N Kokot;G Gibney;M Atkins;M Shaheen;J Warneke;A Ikeguchi;J Eugenio Najero;B Chmielowski;J Crompton;J Floyd;E Hsueh;K Margolin;W Chow;K Grossmann;E Dietrich;V Prieto;M Lowe;E Buchbinder;J Kirkwood;L Korde;J Moon;E Sharon;V Sondak;A Ribas
Journal / Conference
New England Journal of Medicine Mar 2;388(9):813-823
Year
2023
Research Committee(s)
Melanoma
PMID
PMID36856617
PMC
PMC10410527
Study Number(s)
S1801

Long Non-coding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia

Authors
J Farrar;J Smith;M Othus;B Huang;Y Wang;R Ries;T Hylkema;E Pogosova-Agadjanyan;A Leonti;T Shaw;T Triche;A Gamis;R Aplenc;E Kolb;X Ma;D Stirewalt;T Alonzo;S Meshinchi
Journal / Conference
Journal of Clinical Oncology Jun 1;41(16):2949-2962
Year
2023
Research Committee(s)
Leukemia
PMID
PMID36795987
PMC
PMC10414715
Study Number(s)
S0106, S0112, SWOG-9031, SWOG-9333

Healthcare Professionals’ Lay Definitions of Hope

Authors
D Feldman;H Jazaieri;M O'Rourke;M Bakitas;R Krouse;H Deininger;M Hudson;B Corn
Journal / Conference
Journal of Happiness Studies 24:231-247
Year
2023

Racial and Ethnic Disparity in Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Authors
M Rock;R Vaidya;C Till;J Unger;D Hershman;S Ramsey;A Nehemiah;D Maeng;R Krouse
Journal / Conference
Population Health Management Jan 10. doi: 10.1089/pop.2022.0143. Online ahead of print
Year
2023
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID36625863
Study Number(s)
S0000

Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis

Authors
P Torka;L Pederson;M Knopp;D Poon;J Zhang;B Kahl;H Higley;G Kelloff;JW Friedberg;L Schwartz;W Wilson;J Leonard;N Bartlett;H Schoder;A Ruppert
Journal / Conference
Cancer Medicine Apr;12(7):8211-8217
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID36799072
PMC
PMC10134372

Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer

Authors
N Altorki;X Wang;D Kozono;C Watt;R Landreneau;D Wigle;J Port;D Jones;M Conti;A Ashrafi;M Lieberman;K Yasufuku;S Yang;J Mitchell;H Pass;R Keenan;T Bauer;D Miller;L Kohman;T Stinchcombe;E Vokes
Journal / Conference
New England Journal of Medicine Feb 9;388(6):489-498
Year
2023
Research Committee(s)
Lung
PMID
PMID36780674

Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials

Authors
M Roth;S Parsons;P Ganz;L Wagner;P Hinds;S Alexander;K Bingen;S Bober;J Brackett;D Cella;NL Henry;D Indelicato;RH Johnson;T Miller;S Rosenberg;K Schmitz;G Thanarajasingam;B Reeve;J Salsman
Journal / Conference
Journal of the National Cancer Institute Jan 10;115(1):21-28
Year
2023
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID36266760
PMC
PMC9830479

Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer

Authors
C Hatcher;G Richenberg;S Waterson;L Nguyen;A Joshi;R Carreras-Torres;V Moreno;A Chen;M Gunter;Y Lin;C Qu;M Song;G Casey;J Figueiredo;S Gruber;J Hampe;H Hampel;M Jenkins;T Keku;U Peters;C Tangen;A Wu;D Hughes;M Ruhlemann;J Raes;N Timpson;K Wade
Journal / Conference
Scientific Reports Apr 12;13(1):5968. doi: 10.1038/s41598-023-31840-0
Year
2023
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID37045850
PMC
PMC10097673
Study Number(s)
S0000